Derek Adams's Location
Cambridge, Massachusetts, United States, United States
Derek Adams's Contact Details
Derek Adams work email
- Valid
- Valid
- Valid
- Valid
Derek Adams personal email
n/a
Derek Adams phone numbers
About Derek Adams
Derek Adams is a Chief Executive Officer at Stellular Bio at Stellular Bio. He possess expertise in technology transfer, biotechnology, cell culture, manufacturing, validation and 18 more skills.
Derek Adams Work Experience Details
-
Ceo And PresidentStellular Bio Nov 2022 - PresentWatertown, Ma, UsStellular Bio is a private biotechnology company pioneering platelet-derived regenerative biologic (PRB) therapy to expand the reach of regenerative medicine. Together, the Stellular team has built a robust PRB platform and is rapidly advancing to the clinic with treatments for ocular surface disease. Our lead indication is chronic dry eye in patients with the Sjögren syndrome, a common autoimmune disease. -
Member Board Of DirectorsAllovir Mar 2023 - PresentWaltham, Ma, Us- Nomination and Governance committee member- Compensation committee member -
President And Chief Executive OfficerPlateletbio Mar 2022 - Nov 2022Led strategic transformation from cell therapy-based platform to more nimble acellular regenerative medicine platform
-
Chief Operating OfficerPlateletbio Jul 2021 - Mar 2022- Led internal operations of 50-person preclinical cell therapy company- Established manufacturing strategy and operations capable of supporting clinical-stage asset
-
Chief Technology And Manufacturing OfficerBluebird Bio Mar 2017 - Jul 2021Somerville, Massachusetts, Us- Oversaw Pharmaceutical Sciences and Quality (includes Process and Analytical Development, Vector Manufacturing, Patient Operations, Global Supply Chain, Quality Assurance, and Quality Control)- Oversaw manufacturing (internal and external) and distribution for all products globally- Represented bluebird bio manufacturing and supply considerations to press and investors- Reorganized and scaled Pharmaceutical Sciences to support the launch and commercialization of 4 products - Built and qualified commercial-scale and scalable viral vector manufacturing facility- Built novel supply chain to support the patient treatment pathway in close partnership with commercial team- As part of executive leadership, drove decision and plans to split the company into business units and ultimately into two separate companies – completed in late 2021 -
Svp, CmcEvelo Biosciences Jun 2016 - Mar 2017Cambridge, Ma, Us- Established initial process development function and supply chain for clinical studies- Drove strategy for first product development in conjunction with Research and Business Development leaders and company leadership team -
Svp, CmcEpiva Biosciences Feb 2016 - Jun 2016Merged with Evelo Biosciences in summer 2016
-
Vp, Technical And Strategic Product DevelopmentAlexion Pharmaceuticals, Inc. Jun 2015 - Feb 2016Boston, Massachusetts, Us- Responsible for process and analytical development, global technical services, tech transfer, and global clinical supplies within Alexion Global Operations- Integrated and reorganized the Lexington Process and Analytical Development teams (after Alexion acquisition of Synageva Biopharma) - More than doubled the size of the clinical manufacturing network -
Vice President & Plant Manager, Alexion Rhode Island Manufacturing FacilityAlexion Pharmaceuticals, Inc. Oct 2012 - Jun 2015Boston, Massachusetts, Us- Site head responsible for US commercial and global clinical drug substance manufacturing, engineering, validation, technical services, facilities, logistics and EH&S- Manage global clinical drug supply from drug substance to fill/finish to packaging/labeling to distribution to clinical operations sites- Substantially increased talent-level of workforce and doubled the number staff and more than doubled the output of the Alexion Rhode Island Manufacturing Facility output- Managed team through multiple regulatory inspections from FDA, EMA, PMDA, and Turkish inspectors- Led site through substantial overhaul of quality systems in response to FDA Warning Letter- Reduced bioreactor contaminations frequency to essentially 0%
-
Executive Director & Plant Manager, Alexion Rhode Island Manufacturing FacilityAlexion Pharmaceuticals, Inc. May 2011 - Oct 2012Boston, Massachusetts, Us
-
Director, Upstream DevelopmentAlexion Pharmaceuticals, Inc. Jan 2010 - May 2011Boston, Massachusetts, Us- Adapted CMO upstream production process to fit ARIMF facility in 2 months, attained desired titer on first engineering run- Led a company-wide technology transfer team for several clinical phase products transferred from process development in Cheshire to the clinical production facility in ARIMF- Performed CMC due diligence for two business deals that closed in early 2011, including initial assessments of deal potential, site visits to verify CMC information, and support for CMC language in final contracts
-
Associate Director, Upstream DevelopmentAlexion Pharmaceuticals, Inc. Feb 2008 - Feb 2010Boston, Massachusetts, UsHead of Fermentation and Cell Culture Development at Alexion
-
Development Scientist Iii, Fermentation And Cell Culture DevelopmentAlexion Pharmaceuticals, Inc. Sep 2005 - Feb 2008Boston, Massachusetts, Us- Developed a scaled-down model of the Eculizumab production process for evaluation of new lots of raw materials and future process changes- Evaluated and transferred a toxicology/phase I process for an antibody-producing CHO cell line from initial receipt of clone to pilot plant within 4 months- Developed 10 000L-scale stirred-tank cell-culture bioreactor commercial process for a monoclonal antibody-producing GS-NS0 cell line
-
Senior Process Engineer, Viral Vaccine Technology & EngineeringMerck & Co., Inc. 2000 - 2005Technical Manager for Rotavirus and Varicella bulk vaccine inline technology support- Evaluated, demonstrated, and implemented the use of a new type of culture vessel for virus production resulting in ~$1 million per year increase in plant productivity- Increased production capacity by qualifying an additional robotic handling system for culture vessels. Increased robot throughput by increasing speed and efficiency of cell and medium addition operations- Performed a multivariate analysis of virus potency yield to determine the root cause of declining yields- Authored bulk manufacturing sections of Biologic License Applications for several products
Derek Adams Skills
Technology Transfer
Biotechnology
Cell Culture
Manufacturing
Validation
Biopharmaceuticals
Process Simulation
Fermentation
Pharmaceutical Industry
Life Sciences
Fda
Management
Vaccines
Gmp
Chemical Engineering
Monoclonal Antibodies
Cell
Process Development
Process Engineering
People Management
Lifesciences
U.s. Food And Drug Administration
Cell Biology
Derek Adams Education Details
-
University Of MinnesotaChemical Engineering -
Worcester Polytechnic InstituteChemical Engineering
-
Harvard Business SchoolExecutive Education
Frequently Asked Questions about Derek Adams
What company does Derek Adams work for?
Derek Adams works for Stellular Bio
What is Derek Adams's role at the current company?
Derek Adams's current role is Chief Executive Officer at Stellular Bio.
What is Derek Adams's email address?
Derek Adams's email address is ad****@****lxn.com
What is Derek Adams's direct phone number?
Derek Adams's direct phone number is +120322*****
What schools did Derek Adams attend?
Derek Adams attended University Of Minnesota, Worcester Polytechnic Institute, Harvard Business School.
What skills is Derek Adams known for?
Derek Adams has skills like Technology Transfer, Biotechnology, Cell Culture, Manufacturing, Validation, Biopharmaceuticals, Process Simulation, Fermentation, Pharmaceutical Industry, Life Sciences, Fda, Management.
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial